GRIA1 and pancreatic adenocarcinoma: In contrast, high expression of GRIA1, an ionotropic receptor involved in glutamate signaling, was found to be beneficial in PAAD; indeed, GRIA1 has previously been included in a gene-based risk score system constructed for patients with that tumor36,37.